Legal Representation
Attorney
Brian T. Jaenicke
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description |
|---|---|---|---|
| May 8, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| May 8, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Oct 13, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 12, 2016 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Sep 28, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 28, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 28, 2016 | EXT3 | S | SOU EXTENSION 3 FILED |
| Apr 26, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 23, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Mar 21, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 21, 2016 | EXT2 | S | SOU EXTENSION 2 FILED |
| Sep 26, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 25, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Sep 24, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sep 16, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 16, 2015 | EXT1 | S | SOU EXTENSION 1 FILED |
| Apr 7, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Feb 24, 2015 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Feb 21, 2015 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Feb 12, 2015 | APET | A | ASSIGNED TO PETITION STAFF |
| Feb 3, 2015 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Feb 3, 2015 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 9, 2014 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Aug 12, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 12, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 23, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 8, 2014 | ALIE | A | ASSIGNED TO LIE |
| Jul 8, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jun 18, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 17, 2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 17, 2014 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jun 17, 2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jun 17, 2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 16, 2014 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 1, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 20, 2014 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention or treatment of auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases, excluding pharmaceutical preparations for the treatment of infectious-related diseases including anti-infective, anti-biotic, anti-viral, and anti-fungal preparations
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "ZURVANZ" has no meaning in a foreign language.
Classification
International Classes
005